N@N

Ian Somaiya Maintained (BIIB) at Buy with Decreased Target to $393 on, Mar 5th, 2018

Ian Somaiya of BMO Capital, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $403 to $393 on, Mar 5th, 2018.

Ian has made no other calls on BIIB in the last 4 months.

There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 1 agrees with Ian's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $350 on, Wednesday, January 24th, 2018

These are the ratings of the 4 analyists that currently disagree with Ian

---

• Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
• Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
• Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Friday, January 26th, 2018
• Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $363 on, Friday, January 26th, 2018